Medical Device Innovator Lands Strategic Partner to Accelerate U.S. Expansion
As healthcare systems continue shifting toward outpatient care and at-home recovery, demand is rising for technologies that improve patient outcomes beyond the hospital setting. From post-surgical recovery to vascular health management, providers are increasingly prioritizing mobile, patient-compliant solutions that can extend care into everyday environments.
Shares of Therma Bright Inc. (TSX-V: THRM) (OTCQB: TBRIF) are in focus Tuesday after the company announced a new strategic commercial partnership with Horizon Health, a U.S.-based provider of durable medical equipment with deep ties to major hospital systems and surgical centers.
The agreement includes an initial order of 100 Venowave™ units, marking an important step in Therma Bright’s broader commercialization strategy. The order follows a successful proof-of-concept phase completed in 2025, where the company refined its delivery and support infrastructure for the U.S. market.
Horizon Health brings significant scale to the partnership. The company currently distributes more than 3,000 compression products per month through a network that spans over 50 specialized surgical centers and includes affiliations with institutions such as MedStar Health and the University of Maryland. This existing footprint provides Therma Bright with immediate access to a high-volume channel for vascular recovery solutions.
Venowave™ is designed as a portable compression therapy device aimed at improving blood flow and supporting recovery, particularly for patients transitioning from clinical care to home environments. The device demonstrated strong performance during its evaluation phase, supporting both patient compliance and clinical outcomes in post-procedure settings.
Management at Therma Bright views the partnership as a key inflection point. With operational groundwork established during the pilot phase, the company is now positioned to scale distribution through established healthcare networks rather than building channels from scratch. The relationship with Horizon may also serve as a template for additional partnerships as the company expands across the U.S.
Beyond its core clinical applications, Therma Bright is also exploring new opportunities for Venowave™ within the cosmetic and wellness market. Early feedback suggests potential use cases in areas such as lymphatic drainage and post-procedure recovery in aesthetic clinics, opening a secondary growth channel that could complement its medical device business.
The dual-market strategy highlights a broader trend in healthcare, where technologies initially developed for clinical use are increasingly finding applications in adjacent wellness and recovery segments.
Therma Bright continues to position itself as a developer of advanced medical device technologies, with a portfolio that spans vascular health, diagnostics, and topical treatments. The company’s focus remains on identifying scalable opportunities where its technologies can integrate into existing healthcare delivery systems.
Shares of THRM are unchanged at C$0.065 in Tuesday morning trading, while U.S.-listed shares (TBRIF) are flat at $0.038.
Copyright © 2026 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
View more of this article on AllPennyStocks.com.
About AllPennyStocks.com Media, Inc.:
Founded in 1999, AllPennyStocks.com Media, Inc. is North America's largest and longest running website dedicated exclusively to micro-cap and small-cap insights.
Catering to both Canadian and U.S. markets, AllPennyStocks.com provides a wealth of resources and expert content designed for everyone, from beginner investors to seasoned traders.
AllPennyStocks.com's content is prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals.
Contact:
AllPennyStocks.com Media, Inc.
Email: ads@allpennystocks.com
Phone: (800) 558-4560 Ext: 101
